Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 14,051–14,075 of 27,380 studies, newest first · page 563 of 1096.

April 2018 25

  1. 2018-04-27

    Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity

    ✓ Peer-reviewed Brain scans and imaging NeuroImage

    Key finding: Correlations were overall high in healthy controls (ρ = 0.80 ± 0.04), but showed a significant 17% reduction (p < 0.05) in aMCI/AD patients (ρ = 0.67 ± 0.05). +2 more findings

  2. 2018-04-26

    Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

    ✓ Peer-reviewed Disease mechanisms Acta neuropathologica

    Key finding: CSF Ng was specifically increased in ADD compared to eight other neurodegenerative diseases, including Parkinson's disease (p < 0.0001), frontotemporal dementia (p < 0.0001), and amyotrophic lateral sclerosis (p = 0.0002). +4 more findings

  3. 2018-04-26

    Glutamate Transporter GLT1 Expression in Alzheimer Disease and Dementia With Lewy Bodies

    ✓ Peer-reviewed Biomarkers Frontiers in aging neuroscience

    Key finding: Glial fibrillary acidic protein (GFAP) mRNA expression is significantly increased in AD but not in DLB, whereas GLT1 , vesicular glutamate transporter 1 ( vGLUT1 ) and aldehyde dehydrogenase 1 family member 1 ( ALDH1L1 ) are not modified in AD and DLB when compared with controls. +3 more findings

  4. 2018-04-25

    Accuracy of general hospital dementia diagnoses in England: Sensitivity, specificity, and predictors of diagnostic accuracy 2008-2016

    ✓ Peer-reviewed Disparities Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Dementia diagnosis recording in general hospitals is increasing but remains less likely in some groups.

  5. 2018-04-25

    Anticholinergic drugs and risk of dementia: case-control study

    ✓ Peer-reviewed Getting a diagnosis BMJ (Clinical research ed.)

    Key finding: A robust association between some classes of anticholinergic drugs and future dementia incidence was observed. +2 more findings

  6. 2018-04-25

    ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease

    ✓ Peer-reviewed Treatments Neurology

    Key finding: Although prespecified criteria for testing treatment effects were not met, these data suggest a potential treatment effect in patients with mild AD treated with high-dose crenezumab. +3 more findings

  7. 2018-04-24

    [Late life depression - Diagnosis, pathophysiology and therapeutic strategies]

    ✓ Peer-reviewed Risk factors Fortschritte der Neurologie-Psychiatrie

    Key finding: LLD is associated with various adverse outcomes, such as reduced quality of life, negative impact on physical comorbidities, functional impairments, increased suicide and non-suicide mortality.

  8. 2018-04-24

    Cognitive function trajectories and their determinants in older people: 8 years of follow-up in the English Longitudinal Study of Ageing

    ✓ Peer-reviewed Risk factors Journal of epidemiology and community health

    Key finding: The potential determinants of cognitive decline identified in this study, in particular modifiable risk factors, should be tested in the context of randomised controlled trials. +1 more finding

  9. 2018-04-23

    Subthreshold Amyloid Predicts Tau Deposition in Aging

    ✓ Peer-reviewed Treatments The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: We found evidence for an inverted-U relationship between baseline Aβ levels and Aβ slope in asymptomatic older adults, suggesting a slowing of Aβ accumulation even in cognitively normal adults. +4 more findings

  10. 2018-04-23

    Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β

    ✓ Peer-reviewed Treatments Scientific reports

    Key finding: In silico analyses suggest that aducanumab interacts weakly with the Aβ monomer and may accommodate a variety of peptide conformations, further supporting its selectivity for Aβ aggregates.

  11. 2018-04-23

    Risk factors for non-motor symptoms in Parkinson's disease

    ✓ Peer-reviewed Prevention and risk The Lancet. Neurology

    Key finding: However, current understanding of NMS is incomplete, particularly as a result of the absence of standardisation of outcome definitions and the heterogeneity of the risk factors that are assessed. +1 more finding

  12. 2018-04-23

    A Web-Based Intervention to Help Caregivers of Older Adults With Dementia and Multiple Chronic Conditions: Qualitative Study

    ✓ Peer-reviewed Treatments JMIR aging

    Key finding: Recent evidence suggests that Web-based interventions have the potential to support caregivers by decreasing caregiver stress and burden. +2 more findings

  13. 2018-04-22

    Stress as risk factor for Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Pharmacological research

    Key finding: Preclinical studies have suggested that manipulation of the glucocorticoid milieu can trigger cellular, molecular and behavioral derangement resembling the hallmarks of Alzheimer's Disease (AD). +1 more finding

  14. 2018-04-20

    The experiences and preparedness of family carers for best interest decision-making of a relative living with advanced dementia: A qualitative study

    ✓ Peer-reviewed End-of-life care Journal of advanced nursing

    Key finding: The experiences and preparedness of informal carers is a reflection of their personal response, but the distress experienced highlights the significant need of adequate support availability and of enhancing nursing staffs' dementia expertise to maximize their role in facilitating best interest decision-making. +3 more findings

  15. 2018-04-20

    Atrophy patterns in cerebral amyloid angiopathy with and without cortical superficial siderosis

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: Our findings imply that the current version of the Boston criteria may not be sufficient enough to remove non-CAA cases from a cognitively impaired population, especially in the absence of cSS. +3 more findings

  16. 2018-04-19

    Chronic Stress, Social Isolation, and Perceived Loneliness in Dementia Caregivers

    ✓ Peer-reviewed Risk factors Journal of psychosocial nursing and mental health services

    Key finding: These exogenous factors may lead to perceived stress and perceived loneliness-psychosocial endogenous (subjective) elements of caregiving experience. +4 more findings

  17. 2018-04-19

    Spatial reversal learning defect coincides with hypersynchronous telencephalic BOLD functional connectivity in APP NL-F/NL-F knock-in mice

    ✓ Peer-reviewed Biomarkers Scientific reports

    Key finding: Female APP NL/NL knock-in mice of 3 and 7 months old were compared to age-matched APP NL-F/NL-F mice with increased Aβ42/40 ratio and initial Aβ-plaque deposition around 6 months of age. +1 more finding

  18. 2018-04-19

    Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content

    ✓ Peer-reviewed Mild cognitive impairment Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: We believe this to be the first demonstration of myelin loss in MCI, Alzheimer's disease, and vascular dementia using a method that provides a quantitative magnetic resonance imaging-based measure of myelin. +1 more finding

  19. 2018-04-19

    Connected speech and language in mild cognitive impairment and Alzheimer's disease: A review of picture description tasks

    ✓ Peer-reviewed Digital health tools Journal of clinical and experimental neuropsychology

    Key finding: Our review shows that picture description tasks are useful tools for detecting differences in a wide variety of language and communicative measures. +1 more finding

  20. 2018-04-19

    What does the general public understand about prevention and treatment of dementia? A systematic review of population-based surveys

    ✓ Peer-reviewed Prevention and risk PloS one

    Key finding: Knowledge among those living in low- and middle-income countries are largely unknown, presenting challenges for the development of National action plans consistent with World Health Organization directives. +3 more findings

  21. 2018-04-18

    Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice

    ✓ Peer-reviewed Genetics Neuroscience

    Key finding: The ApoE ε4 allele (ApoE4) is the single most important genetic risk-factor for Alzheimer's disease (AD) while the ε2 allele (ApoE2) is associated with a lower risk of AD-related neurodegeneration compared to the most common variant, ε3 (ApoE3). +3 more findings

  22. 2018-04-18

    Mechanism of NMDA receptor channel block by MK-801 and memantine

    ✓ Peer-reviewed Treatments Nature

    Key finding: The NMDA (N-methyl-D-aspartate) receptor transduces the binding of glutamate and glycine, coupling it to the opening of a calcium-permeable ion channel 1 . +3 more findings

  23. 2018-04-18

    Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice

    ✓ Peer-reviewed Biomarkers Journal of neuroinflammation

    Key finding: These findings indicate that galantamine could be a promising treatment to improve endotoxin-induced cognitive decline and neuroinflammation in neurodegenerative diseases. +2 more findings

  24. 2018-04-18

    Mild TBI and risk of Parkinson disease: A Chronic Effects of Neurotrauma Consortium Study

    ✓ Peer-reviewed Prevention and risk Neurology

    Key finding: Among military veterans, mTBI is associated with 56% increased risk of PD, even after adjusting for demographics and medical/psychiatric comorbidities. +3 more findings

  25. 2018-04-17

    Inflammation in CNS neurodegenerative diseases

    ✓ Peer-reviewed Inflammation and the immune system Immunology

    Key finding: Despite the different aetiologies, for example, infections, genetic mutations, trauma and protein aggregations, neuronal damage is frequently associated with chronic activation of an innate immune response in the CNS.

Browse the library by subject, with the full score breakdown →